临床普外科电子杂志
臨床普外科電子雜誌
림상보외과전자잡지
Journal of General Surgery for Clinicians (Electronic Version)
2014年
3期
23-25
,共3页
步向阳%陈斌%李洪%乐嘉芳%王一%葛忠
步嚮暘%陳斌%李洪%樂嘉芳%王一%葛忠
보향양%진빈%리홍%악가방%왕일%갈충
原发性肝癌%手术切除%复发%射频消融
原髮性肝癌%手術切除%複髮%射頻消融
원발성간암%수술절제%복발%사빈소융
Primary liver carcinoma%Recurrence%Hepatic resection%Radiofrequency ablation
目的:比较手术切除和射频消融治疗根治性切除术后复发性小肝癌(≤3cm)的临床疗效。方法52例小肝癌患者,手术切除25例,射频消融27例,分析临床资料及随访结果。结果全组中位随访时间27(8~43)个月。手术组与射频组比较1、2、3年无瘤生存率为76.0%、48.0%、32.0%vs 77.8%、51.9%、37.1%,平均无瘤生存时间为21.4个月vs 23.5个月,总1、2、3年累积生存率为92.0%、80.0%、68.0%vs 92.6%、74.1%、63.0%,平均生存时间为35.8个月vs 32.7个月。无瘤生存率与累积生存率差别均无统计学意义。结论射频消融治疗对于直径≤3cm的切除术后复发性小肝癌疗效确切,近远期疗效与手术切除相近,可以考虑作为其首选的治疗手段之一。
目的:比較手術切除和射頻消融治療根治性切除術後複髮性小肝癌(≤3cm)的臨床療效。方法52例小肝癌患者,手術切除25例,射頻消融27例,分析臨床資料及隨訪結果。結果全組中位隨訪時間27(8~43)箇月。手術組與射頻組比較1、2、3年無瘤生存率為76.0%、48.0%、32.0%vs 77.8%、51.9%、37.1%,平均無瘤生存時間為21.4箇月vs 23.5箇月,總1、2、3年纍積生存率為92.0%、80.0%、68.0%vs 92.6%、74.1%、63.0%,平均生存時間為35.8箇月vs 32.7箇月。無瘤生存率與纍積生存率差彆均無統計學意義。結論射頻消融治療對于直徑≤3cm的切除術後複髮性小肝癌療效確切,近遠期療效與手術切除相近,可以攷慮作為其首選的治療手段之一。
목적:비교수술절제화사빈소융치료근치성절제술후복발성소간암(≤3cm)적림상료효。방법52례소간암환자,수술절제25례,사빈소융27례,분석림상자료급수방결과。결과전조중위수방시간27(8~43)개월。수술조여사빈조비교1、2、3년무류생존솔위76.0%、48.0%、32.0%vs 77.8%、51.9%、37.1%,평균무류생존시간위21.4개월vs 23.5개월,총1、2、3년루적생존솔위92.0%、80.0%、68.0%vs 92.6%、74.1%、63.0%,평균생존시간위35.8개월vs 32.7개월。무류생존솔여루적생존솔차별균무통계학의의。결론사빈소융치료대우직경≤3cm적절제술후복발성소간암료효학절,근원기료효여수술절제상근,가이고필작위기수선적치료수단지일。
Objective To compare clinical results on surgical resection(SR) and radiofrequency ablation(RFA) for the treatment of the patients with recurrence small primary liver carcinoma with the diameter smaller than 3 cm after curative resection. Methods The clinical results on 52 patients were analyzed. Of 52 patients,25 underwent surgical resection and 27 did radiofrequency ablation. Results With media follow-up time 27(8~43) months, the 1,2,3-year disease free survival rates in SR and RFA group were 76.0%,48.0%and 32.0%vs 77.8%,51.9%and 37.1%, the mean disease free survival time were 21.4 vs 23.5months. The 1,2,3-year cumulative survival rates in SR and RFA group were 92.0%,80.0%and 68.0%vs 92.6%,74.1%and 63.0%, the mean cumulative survival time were 35.8 vs 32.7 months. The 1,2,3-year disease free survival rates and cumulative survival rates in SR and RFA group were statistically not significant. Conclusion Radiofreqency ablation is a safe and satisfactory treatment for the treatment of the patients with recurrence small liver carcinoma with the diameter smaller than 3 cm after curative resection with short and long-time results that similar to surgical resection, which can be selected as one of the first-line treatments.